Viatris (VTRS) Earnings Date & Reports

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

VTRS is expected to report earnings to fall 5.72% to 65 cents per share on November 09

Q3'26

Est.

$0.65

Q2'26

Beat

by $0.08

Q1'26

Beat

by $0.08

Q4'25

Beat

by $0.03

Q3'25

Beat

by $0.05

The last earnings report on August 06 showed earnings per share of 68 cents, beating the estimate of 61 cents. With 4.10M shares outstanding, the current market capitalization sits at 18.75B.

View a ticker or compare two or three

VTRS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days